Japan and UK eye fall launch for $20bn global vaccine alliance

Partners aim to counter financial power of US and China to secure deals

20200810N vaccine

Japan and the U.K. hope to gain a financial advantage by forming a procurement alliance for a coronavirus vaccine. (Getty Images)

TAKUYA MIZOROGI, Nikkei staff writer

TOKYO -- Japan, the U.K. and more than 70 other countries plan to form an alliance this fall to jointly procure 2 billion doses of coronavirus vaccines by 2021, looking to gain financial leverage in talks with pharmaceutical companies. 

The partnership, initially pitched around June by Japan, the U.K., Germany, France and the European Union, aims to pool up to $20 billion. The alliance, named Covax, will pay vaccine makers in advance and procure doses for member countries. Supplies for individual nations will be capped at 20% of the population.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.